Why ASCI?
ASCI uses our own immune system to attack cancer. It does this by educating our immune system to identify and attack antigens displayed on cancer cells.
The immune system reacts towards the antigens in ASCI – a reaction called immune response – and then attacks the cancer cells where this antigen is found.
The first antigen investigated by GSK for use in ASCI is called MAGE-A3; it is a cancer-specific antigen found in several types of cancer including lung cancer, melanoma and bladder cancer.
